Overview

The Letrozole Administration During Luteal Phase

Status:
Unknown status

Trial end date:
2017-03-01

Target enrollment:

Participant gender:

Summary

To investigate the effect of letrozole in patients who have high risk of ovarian hyperstimulation syndrome (OHSS) after oocyte retrieval, the incidence of OHSS were calculated between letrozole group and supporting treatment group.

Phase:

Phase 3

Details

Lead Sponsor:

The Affiliated Hospital of Inner Mongolia Medical University

Treatments:

BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Letrozole
Polygeline